Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells

Journal of Gastrointestinal Surgery

Volumn 7, Issue 1, 2003, Pages 68-76

  Jones, Andrew D ^a   Bacon, Kathy D ^a   Jobe, Blair A ^a   Sheppard, Brett C ^a   Deveney, Clifford W ^a   Rutten, Michael J ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Apoptosis; Barrett's; Esophagus; Helicobacter pylori

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; CAGE PROTEIN; FAS ANTIGEN; PICB PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; CAGA PROTEIN, HELICOBACTER PYLORI; FAS PROTEIN, HUMAN; NEUROPEPTIDE; PICB PROTEIN, HELICOBACTER PYLORI; TUMOR NECROSIS FACTOR RECEPTOR;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BARRETT ESOPHAGUS; BIOTECHNOLOGY; CARCINOMA CELL; CONTROLLED STUDY; ESOPHAGUS; ESOPHAGUS CARCINOMA; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; HUMAN TISSUE; MUTANT; NONHUMAN; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WILD TYPE; CELL CULTURE; ESOPHAGUS TUMOR; GENETICS; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOCARCINOMA; ANTIGENS, BACTERIAL; ANTIGENS, CD95; APOPTOSIS; BACTERIAL PROTEINS; BARRETT ESOPHAGUS; BLOTTING, WESTERN; CELLS, CULTURED; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; HELICOBACTER PYLORI; HUMANS; NEUROPEPTIDES; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR CELLS, CULTURED;

EID: 0037267029     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00129-4     Document Type: Article

References (73)

1. El-Omar E.M., Oien K., El-Nujumi A., Gillen D., Wirz A., Dahill S., Williams C., Ardill J.E., McColl K.E. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology. 113:1997;15-24.
2. Falk G.W. GERD and H. pylori. Is there a link? Semin Gastrointest Dis. 12:2001;16-25.
3. Devesa S.S., Blot W.J., Fraumeni J.F. Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053.
4. Loffeld R.J., Werdmuller B.F., Kuster J.G., Perez-Perez G.I., Blaser M.J., Kuipers E.J. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus. Digestion. 62:2000;95-99.
5. Wright T.A., Myskow M., Kingsnorth A.N. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer. Dis Esoph. 10:1997;196-200.
6. el-Serag H.B., Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut. 43:1998;327-333.
7. Weston A.P., Badr A.S., Topalovski M., Cherian R., Dixon A., Hassanein R.S. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol. 95:2000;387-394.
8. Vieth M., Masoud B., Meining A., Stolte M. Helicobacter pylori infection. Protection against Barrett's mucosa and neoplasia? Digestion. 62:2000;225-231.
9. Vaezi M.F., Falk G.W., Peek R.M., Vicari J.J., Goldblum J.R., Perez-Perez G.I., Rice T.W., Blaser M.J., Richter J.E. CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol. 95:2000;2206-2211.
10. Lord R.V., Frommer D.J., Inder S., Tran D., Ward R.L. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust NZ J Surg. 70:2000;26-33.
11. Blaser M.J. Hypothesis. The changing relationships of Helicobacter pylori and humans: Implications for health and disease J Infect Dis. 179:1999;1523-1530.
12. Werdmuller B.F., Loffeld R.J. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci. 42:1997;103-105.
13. Varanasi RV FG, Wilson KT. Decreased prevalance of H. pylori infection in gastroesophageal reflux disease. Helicobacter 1998;188-194.
14. Labenz J., Blum A.L., Bayerdorffer E., Meining A., Stolte M., Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology. 112:1997;1442-1447.
15. Ormsby A.H., Vaezi M.F., Richter J.E., Goldblum J.R., Rice T.W., Falk G.W., Gramlich T.L. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology. 119:2000;683-690.
16. Richter J.E., Falk G.W., Vaezi M.F. Helicobacter pylori and gastroesophageal reflux disease. The bug may not be all bad Am J Gastroenterol. 93:1998;1800-1802.
17. Richter J. Do we know the cause of reflux disease? Eur J Gastroenterol Hepatol. 11:1999;S3-S9.
18. Peek R.M. Jr., Vaezi M.F., Falk G.W., Goldblum J.R., Perez-Perez G.I., Richter J.E., Blaser M.J. Role of Helicobacter pylori cagA(+) strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia. Int J Cancer. 82:1999;520-524.
19. Wu J.C., Sung J.J., Chan F.K., Ching J.Y., Ng A.C., Go M.Y., Wong S.K., Ng E.K., Chung S.C. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 14:2000;427-432.
20. Fan X., Crowe S.E., Behar S., Gunasena H., Ye G., Haeberle H., Van Houten N., Gourley W.K., Ernst P.B., Reyes V.E. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells. a mechanism for T helper cell type 1-mediated damage J Exp Med. 187:1998;1659-1669.
21. Fan X., Gunasena H., Cheng Z., Espejo R., Crowe S.E., Ernst P.B., Reyes V.E. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J Immunol. 165:2000;1918-1924.
22. Rudi J., Kuck D., Strand S., von Herbay A., Mariani S.M., Krammer P.H., Galle P.R., Stremmel W. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest. 102:1998;1506-1514.
23. Peek R.M. Jr., Blaser M.J., Mays D.J., Forsyth M.H., Cover T.L., Song S.Y., Krishna U., Pietenpol J.A. Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle. Cancer Res. 59:1999;6124-6131.
24. Peek R.M. Jr., Moss S.F., Tham K.T., Perez-Perez G.I., Wang S., Miller G.G., Atherton J.C., Holt P.R., Blaser M.J. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst. 89:1997;863-868.
25. Shirin H., Moss S.F. Helicobacter pylori induced apoptosis. Gut. 43:1998;592-594.
26. Szabo I., Tarnawski A.S. Apoptosis in the gastric mucosa. molecular mechanisms, basic and clinical implications J Physiol Pharmacol. 51:2000;3-15.
27. Watanabe S., Takagi A., Koga Y., Kamiya S., Miwa T. Helicobacter pylori induces apoptosis in gastric epithelial cells through inducible nitric oxide. J Gastroenterol Hepatol. 15:2000;168-174.
28. Wang J., Fan X., Lindholm C., Bennett M., O'Connoll J., Shanahan F., Brooks E.G., Reyes V.E., Ernst P.B. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect Immun. 68:2000;4303-4311.
29. Zhang Z., Yuan Y., Gao H., Dong M., Wang L., Gong Y.H. Apoptosis, proliferation and p53 gene expression of H. pylori associated gastric epithelial lesions. World J Gastroenterol. 7:2001;779-782.
30. Kim J.M., Kim J.S., Jung H.C., Song I.S., Kim C.Y. Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection. Possible involvement of neutrophils through tumor necrosis factor alpha and soluble Fas ligands Scand J Gastroenterol. 35:2000;40-48.
31. Moss S.F., Calam J., Agarwal B., Wang S., Holt P.R. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut. 38:1996;498-501.
32. Le'Negrate G., Ricci V., Hofman V., Mograbi B., Hofman P., Rossi B. Epithelial intestinal cell apoptosis induced by Helicobacter pylori depends on expression of the cag pathogenicity island phenotype. Infect Immun. 69:2001;5001-5009.
33. Fitzgerald R.C., Farthing M.J., Triadafilopoulos G. Novel adaptation of brush cytology technique for short-term primary culture of squamous and Barrett's esophageal cells. Gastrointest Endosc. 54:2001;186-189.
34. de Both N.J., Wijnhoven B.P., Sleddens H.F., Tilanus H.W., Dinjens W.N. Establishment of cell lines from adenocarcinomas of the esophagus and gastric cardia growing in vivo and in vitro. Virchows Arch. 438:2001;451-456.
35. Constant-Neto M., Falavigna M., Castro A.C., Machado D.C. Method to obtain endoscopic esophageal samples for primary cell culture. Focus on infectious contamination Dig Dis Sci. 45:2000;1667-1669.
36. Tobey N.A., Koves G., Orlando R.C. Human esophageal epithelial cells possess an Na+/H+ exchanger for H+ extrusion. Am J Gastroenterol. 93:1998;2075-2081.
37. Tummuru M.K., Cover T.L., Blaser M.J. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect Immun. 62:1994;2609-2613.
38. Atherton J.C., Cao P., Peek R.M. Jr., Tummuru M.K., Blaser M.J., Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 270:1995;17771-17777.
39. Sharma S.A., Tummuru M.K., Blaser M.J., Kerr L.D. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcription factor nuclear factor-kappa B in gastric epithelial cells. J Immunol. 160:1998;2401-2407.
40. Peek R.M. Jr., Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev Cancer. 2:2002;28-37.
41. Peek R.M. Jr. Helicobacter pylori strain-specific activation of signal transduction cascades related to gastric inflammation. Am J Physiol. 280:2001;G525-G530.
42. Kidd M., Peek R.M., Lastovica A.J., Israel D.A., Kummer A.F., Louw J.A. Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Gut. 49:2001;629-635.
43. Tham K.T., Peek R.M. Jr., Atherton J.C., Cover T.L., Perez-Perez G.I., Shyr Y., Blaser M.J. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol. 32:2001;264-273.
44. Papini E., Zoratti M., Cover T.L. In search of the Helicobacter pylori VacA mechanism of action. Toxicon. 39:2001;1757-1767.
45. Maeda S., Yoshida H., Mitsuno Y., Hirata Y., Ogura K., Shiratori Y., Omata M. Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori. Gut. 50:2002;771-778.
46. Jones N.L., Day A.S., Jennings H.A., Sherman P.M. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun. 67:1999;4237-42342.
47. Montecucco C., Rappuoli R. Living dangerously. How Helicobacter pylori survives in the human stomach Nat Rev Mol Cell Biol. 2:2001;457-466.
48. Kawahara T., Kuwano Y., Teshima-Kondo S., Sugiyama T., Kawai T., Nikawa T., Kishi K., Rokutan K. Helicobacter pylori lipopolysaccharide from type I, but not type II strains, stimulates apoptosis of cultured gastric mucosal cells. J Med Invest. 48:2001;167-174.
49. Asahi M., Azuma T., Ito S., Ito Y., Suto H., Nagai Y., Tsubokawa M., Tohyama Y., Maeda S., Omata M., Suzuki T., Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med. 191:2000;593-602.
50. Meyer F., Wilson K.T., James S.P. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun. 68:2000;6265-6272.
51. Selbach M., Moese S., Meyer T.F., Backert S. Functional analysis of the Helicobacter pylori cag pathogenicity island reveals both VirD4-CagA-dependent and VirD4-CagA-independent mechanisms. Infect Immun. 70:2002;665-671.
52. Backert S., Ziska E., Brinkmann V., Zimny-Arndt U., Fauconnier A., Jungblut P.R., Naumann M., Meyer T.F. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol. 2:2000;155-164.
53. Selbach M., Moese S., Hauck C.R., Meyer T.F., Backert S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem. 277:2002;6775-6778.
54. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., Shi Y.F. Death the Fas way. Regulation and pathophysiology of CD95 and its ligand Pharmacol Ther. 88:2000;333-347.
55. Bennett M.W., O'Connell J., O'Sullivan G.C., Roche D., Brady C., Collins J.K., Shanahan F. Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium. A potential mechanism of apoptotic epithelial turnover Dis Esoph. 12:1999;90-98.
56. Younes M., Schwartz M.R., Finnie D., Younes A. Overexpression of Fas ligand (FasL) during malignant transformation in the large bowel and in Barrett's metaplasia of the esophagus. Hum Pathol. 30:1999;1309-1313.
57. Shibakita M., Tachibana M., Dhar D.K., Ohno S., Kubota H., Yoshimura H., Kinugasa S., Masunaga R., Nagasue N. Spontaneous apoptosis in advanced esophageal carcinoma. Its relation to Fas expression Clin Cancer Res. 6:2000;4755-4759.
58. Kase S., Osaki M., Adachi H., Kaibara N., Ito H. Expression of Fas and Fas ligand in esophageal tissue mucosa and carcinomas. Int J Oncol. 20:2002;291-297.
59. Labenz J. Consequences of Helicobacter pylori cure in ulcer patients. Baillieres Best Pract Res Clin Gastroenterol. 14:2000;133-145.
60. Fujimori T., Kawamata H., Ichikawa K., Ono Y., Okura Y., Tomita S., Imura J. Pathological issues of gastric and lower esophageal cancer. Helicobacter pylori infection and its eradication J Gastroenterol. 37:2002;28-33.
61. Schwartz M.D. Dyspepsia, peptic ulcer disease, and esophageal reflux disease. West J Med. 176:2002;98-103.
62. Sonnenberg A. What to do about Helicobacter pylori? A decision analysis of its implication on public health. Helicobacter. 7:2002;60-66.
63. Koop H. Gastroesophageal reflux disease and Barrett's esophagus. Endoscopy. 34:2002;97-103.
64. Csendes A., Smok G., Cerda G., Burdiles P., Mazza D., Csendes P. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esoph. 10:1997;38-42.
65. Cameron A.J., Souto E.O., Smyrk T.C. Small adenocarcinomas of the esophagogastric junction. Association with intestinal metaplasia and dysplasia Am J Gastroenterol. 97:2002;1375-1380.
66. Oberg S., Peters J.H., Nigro J.J., Theisen J., Hagen J.A., DeMeester S.R., Bremner C.G., DeMeester T.R. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg. 134:1999;722-726.
67. Pace F., Bianchi Porro G. Gastro-oesophageal reflux and Helicobacter pylori. Ital J Gastroenterol Hepatol. 30:1998;S289-S293.
68. Henrik Siman J., Forsgren A., Berglund G., Floren C.H. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms. Helicobacter. 6:2001;310-316.
69. Wu J.C., Sung J.J., Ng E.K., Go M.Y., Chan W.B., Chan F.K., Leung W.K., Choi C.L., Chung S.C. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease. A study from the East Am J Gastroenterol. 94:1999;1790-1794.
70. Fallone C.A., Barkun A.N., Gottke M.U., Best L.M., Loo V.G., Veldhuyzen van Zanten S., Nguyen T., Lowe A., Fainsilber T., Kouri K., Beech R. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am J Gastroenterol. 95:2000;659-669.
71. Arents N.L., van Zwet A.A., Thijs J.C., Kooistra-Smid A.M., van Slochteren K.R., Degener J.E., Kleibeuker J.H., van Doorn L.J. The importance of vacA, cagA, and iceA genotypes of Helicobacter pylori infection in peptic ulcer disease and gastroesophageal reflux disease. Am J Gastroenterol. 96:2001;2603-2608.
72. Peek R.M. Jr. The biological impact of Helicobacter pylori colonization. Semin Gastrointest Dis. 12:2001;151-166.
73. Vakil N.B. Review article. Gastro-oesophageal reflux disease and Helicobacter pylori infection Aliment Pharmacol Ther. 16:2002;47-51.